From next year, these drugs will not be covered by health insurance.

"Pharmaceutical Network Industry Dynamics" On September 14, Shaanxi Medical Insurance Bureau issued "On the transfer of some drugs out of Shaanxi Province basic medical insurance payment scope of publicity."
of these, a total of 63 drugs were included in the list of the first batch of digestive drugs in Shaanxi Province, involving aluminum hydroxide, moshapili, metformin margarine, quanneiderxine, keromycin, aminol chloride pseudo-hemp, acetaminophen Moxirin bichloroxilin, compound cephalosporine, compound licorice, axilovy, gluten, fennel positive air drops, chrysanthepine particles, cough flat breath oral solution, double red live blood capsules and many other large varieties, common drugs.
, the announcement also showed that the listed drugs will be excluded from the Shaanxi Provincial Health Insurance Fund payment range from January 1, 2021.
publicity period is from 14 September to 19 September.
it is understood that the Shaanxi Medical Insurance Bureau issued a public announcement, the transfer of 63 drugs, mainly in order to implement the relevant documents of the State Health Insurance Administration requirements, on time to complete the shaanxi Province to supplement the class B drug digestion task.
is well known that before the 2019 edition of the Medicare drug catalog, 15 percent of Class B drugs were adjustable permissions for local catalogs, creating a so-called "local supplemental catalogue."
However, after the publication of the 2019 edition of the catalogue, the State Health Insurance Administration explicitly proposed to abolish the local supplement catalogue, that is, "except for special provisions, the local no longer carry out class B drug adjustment, the original added varieties should in principle be gradually digested within 3 years, and priority should be given to digesting the varieties included in the scope of national key monitoring."
2020-2022 is a transitional period for provincial health-care departments to "digest inventory" according to the National Health Insurance Administration's unified requirements.
fact, the author through combing found that from the end of 2019, the provinces have started the provincial directory and the new version of the national health insurance directory docking work.
Up to now, including Gansu, Ningxia, Xinjiang, Guangxi, Zhejiang, a total of more than 20 provinces have landed to implement the local supplement directory transfer policy - among them, Yunnan, Hunan, Jilin, Tianjin, Hebei, Anhui, Tibet and other places have clearly the first batch of additional varieties of local health insurance, a large number of varieties have been transferred out of the local health insurance directory on July 1, 2020; Today, April 22,
, Anhui Provincial Health Insurance Bureau issued the "Anhui Province Basic Medical Insurance, Industrial Injury Insurance and Maternity Insurance Drug Catalog Digestion Implementation Plan (Draft for Comments)", clearly in the adoption of the principle of gradual adjustment and smooth transition, within three years to complete the digestion of the province's updated catalogue, by the end of December 2020 announced all digested varieties.
specific digestive varieties will not be announced until the end of the year.
June 8th, the Chongqing Municipal Health Insurance Bureau issued the "Public Notice on chongqing's gradual digestion of the list of locally supplemented medical insurance Class B drugs", and also indicated that it would gradually digest the local supplement of Health Insurance Class B drugs within three years.
, Chongqing medical insurance supplement adjustment time is divided into three time periods, from June 2020 the first batch of state-focused monitoring of reasonable drug varieties of drugs will no longer be included in the city's medical insurance reimbursement.
January 1, 2012, drugs with approval number "Drug Code B" and no purchasing data at the Drug Exchange in 2019 will no longer be included in the medicare reimbursement.
Overall, with the abolition of local health insurance supplement authority, the normal adjustment of the national version of the health insurance catalog will undoubtedly become an important window of opportunity for pharmaceutical companies, this year's health care negotiations will be held in October-November, the relevant pharmaceutical companies need to focus on.
.